Pioneering the Future of Regenerative Aesthetics
On the 17th of March 2025, the prestigious Royal Society of Medicine hosted the highly anticipated RAES 15th UK Regenerative Aesthetic ExoCoBio Summit 2025.
The event brought together some of the leading minds in regenerative aesthetics and exosome-based treatments, offering an insightful and engaging programme that explored the latest advancements in this cutting-edge field.
The day commenced with a welcome reception, where delegates from across the aesthetic and regenerative medicine sectors gathered for networking and introductions.
Following this, a series of expert-led talks and panel discussions delved into the role of exosomes in regenerative aesthetics, focusing on their revolutionary applications in skin rejuvenation, wound healing, and non-surgical interventions.
Dr. Munir Somji delivered a compelling presentation on the clinical applications of exosome-based therapies within aesthetic medicine, sharing insights from his extensive experience in pioneering innovative treatments.
His talk was followed by Dr. Apul Parikh, who provided an in-depth look at the actual exosome product being used in regenerative treatments. Dr. Parikh discussed how the product is manufactured, explaining the rigorous processes that ensure its exceptional purity and efficiency compared to competitors. He touched on the fundamentals of its mechanism of action—how exosomes work at the cellular level to stimulate regeneration— before showcasing a selection of clinical photos demonstrating impressive patient outcomes.
Dr. Ayah Siddiqi later took to the stage, discussing the latest developments in skin health and rejuvenation, highlighting the promising role exosomes play in advancing dermatological treatments.
The afternoon featured an in-depth panel discussion where the speakers addressed emerging trends, ongoing research, and the future potential of exosome applications in regenerative aesthetics.
A lively Q&A session encouraged audience participation, allowing attendees to pose questions and gain deeper insights from the expert panel.
Throughout the day, delegates also enjoyed ample opportunities for networking and discussion over lunch and refreshment breaks.
About ExoCoBio
Founded in 2017, ExoCoBio is a global leader in exosome-based regenerative aesthetics and medicine. The company is dedicated to developing and manufacturing innovative exosome products for skin and hair regeneration, including their best-selling ASCE+™ and ERC™ lines. With over 3.5 million cases sold since 2019, ExoCoBio continues to push the boundaries of regenerative science. In 2023, ExoCoBio expanded its global presence with the acquisition of BENEV, a U.S.-based medical aesthetic company, further cementing its role at the forefront of exosome technology.
The Cure Medical team are unrivalled medical aesthetic device specialists with a medical aesthetic background, offering the latest technology and solutions for hundreds of clinics in the UK. Cure Medical are committed to providing the latest aesthetic technology and devices at the leading edge of the global aesthetics industry. Every product in their portfolio has been designed to transform and elevate a practice, providing a solution the market asks for. Excelling in end-to-end support from the machine sale to business strategy, marketing solutions, development and growth, Cure Medical offer much more than the machines they deliver and provide expertise to increase the opportunity of growth.
